Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema

Recruiting now · Not applicable

Conditions studied: Breast Cancer, Breast Cancer Related Lymphedema, Lymphedema of Upper Arm

In brief

Up to one out of five patients with breast cancer will develop lymphedema in the upper extremity after cancer treatment. Patients with breast cancer-related lymphedema (BCRL) suffer from pain, heaviness, tightness, and a decreased range of motion. Photobiomodulation therapy (PBMT) is a non-invasive therapy based on the application of visible and/or near-infrared light produced by a laser diode or a light-emitting diode. The scientifically proven biologic effects of PBM are improved wound healing, and a reduction in pain, inflammation, and oedema. Therefore, the aim of this study is to evaluate the effectiveness of PBMT on the management of BCRL.

Key facts

Study ID
NCT04690439
Run by
Jessa Hospital
People needed
104
Starts
2021-02-22
Expected to finish
2028-02-01
Last updated by the study team
2023-02-28

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.